SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 152.31-1.6%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: juneau_boy who wrote (546)3/22/2000 10:35:00 AM
From: aknahow  Read Replies (2) of 1834
 
No concern either, but interested in who proposed this as measure of anything and what profitable use was made of this theory?

Oil companies have a very high cap per employee, and while biotechs are obviously different over staffing would lead to a lower, "better" ratio. This does not mean I would consider a higher ratio as good, but rather that the concept is meaningless as a measure of value for biotechs. But I am interested in seeing any study which indicates I am wrong about this.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News